Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease.
Centorame A, Dumut DC, Youssef M, Ondra M, Kianicka I, Shah J, Paun RA, Ozdian T, Hanrahan JW, Gusev E, Petrof B, Hajduch M, Pislariu R, De Sanctis JB, Radzioch D.
Centorame A, et al. Among authors: dumut dc.
Front Pharmacol. 2022 May 20;13:876842. doi: 10.3389/fphar.2022.876842. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35668939
Free PMC article.